Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927223 · ClinicalTrials.gov registry record · NA
Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02927223: Completed NA study, sponsored by Vanderbilt University.
NCT02927223 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02927223, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.
Interventions
- DRUG Atropine
- PROCEDURE Exercise treadmill test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-02 |
| Phase | NA |
What the finished NCT02927223 record still lists
NCT02927223 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Atropine is the first listed.
NCT02927223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02927223 about?
NCT02927223 is a clinical study titled "Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)". To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.
What is the current status of trial NCT02927223?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2016-10. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02927223?
The interventions under investigation include: Atropine (DRUG), Exercise treadmill test (PROCEDURE).
Who is sponsoring clinical trial NCT02927223?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02927223's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia